Description
SeQuent® Please OTW features an optimized and clinically proven drug-coating technology which facilitates the safe and effective treatment of patients with peripheral arterial disease (PAD) in above and below the knee indications. [1, 2]
Controlled and effective drug dosage of Paclitaxel
- Drug Dosage 3μg/mm2
- Effective reduction of TLR compared to uncoated balloons
- Homogeneous coating even in the balloon folds exceeding distal and proximal markers
Resveratrol: A hydrophilic excipient
- Naturally occurring, plant-based substance
- Acts as hydrophilic spacer and makes the Paclitaxel bioavailable
- Enables controlled drug transfer into vessel wall
Mechanically resistant coating [3]
- Low drug loss in simulated use (<2 %)
- High available drug dose at inflation
- Designed for technical success
- Kink resistant shaft
- Low crossing profile